Trials / Completed
CompletedNCT01376674
T-cell-immunity During Standard Radiotherapy in Localised Prostate Cancer
Changes of T-cell-immune-status During Curative Radiotherapy in Prostate Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 22 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Immunological effects of radiotherapy have been described before, but not evaluated in a time-dependant manner. In order to identify a possible time frame for combination therapies, white blood cells are isolated of samples taken at different time points before during and after standard radiotherapy in patients with localised prostate cancer. The overall activity of the T-cell-system as well as tumor-specific T-cell-response are evaluated.
Conditions
Timeline
- Start date
- 2011-03-01
- First posted
- 2011-06-20
- Last updated
- 2013-08-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01376674. Inclusion in this directory is not an endorsement.